Targeting glutamine metabolism in SDH deficient cancer is emerging as an ongoing trial (NCT02071862) including, inter alia, SDH associated gastrointestinal stromal tumors and non-gastrointestinal stromal tumors. Here, SDHB is linked to gastrointestinal stromal tumor.